CTCFL | CCCTC-binding factor (zinc finger protein)-like | Predicted membrane proteins Transcription factors
| | | | | Tissue enriched |
CUX1 | Cut-like homeobox 1 | Cancer-related genes Predicted membrane proteins Transcription factors
| | | | | Expressed in all |
CXXC1 | CXXC finger protein 1 | Transcription factors
| | | | | Expressed in all |
DDIT3 | DNA-damage-inducible transcript 3 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
DEAF1 | DEAF1 transcription factor | Predicted secreted proteins Transcription factors
| | | | | Expressed in all |
DMRT1 | Doublesex and mab-3 related transcription factor 1 | Disease related genes Transcription factors
| | | | | Tissue enriched |
DMRTB1 | DMRT-like family B with proline-rich C-terminal, 1 | Transcription factors
| | | | | Tissue enriched |
DMTF1 | Cyclin D binding myb-like transcription factor 1 | Transcription factors
| | | | | Expressed in all |
DNAJC2 | DnaJ (Hsp40) homolog, subfamily C, member 2 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
DNMT1 | DNA (cytosine-5-)-methyltransferase 1 | Disease related genes Enzymes FDA approved drug targets Plasma proteins Transcription factors
| | | | | Expressed in all |
DNMT3A | DNA (cytosine-5-)-methyltransferase 3 alpha | Cancer-related genes Enzymes Plasma proteins Transcription factors
| | | | | Expressed in all |
E2F1 | E2F transcription factor 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
E2F3 | E2F transcription factor 3 | Cancer-related genes Transcription factors
| | | | | Expressed in all |
E2F4 | E2F transcription factor 4, p107/p130-binding | Transcription factors
| | | | | Expressed in all |
E2F5 | E2F transcription factor 5, p130-binding | Cancer-related genes Predicted membrane proteins Predicted secreted proteins Transcription factors
| | | | | Mixed |
E4F1 | E4F transcription factor 1 | Transcription factors
| | | | | Expressed in all |
EGR1 | Early growth response 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
EGR3 | Early growth response 3 | Transcription factors
| | | | | Mixed |
EHF | Ets homologous factor | Predicted secreted proteins Transcription factors
| | | | | Mixed |
ELF1 | E74-like factor 1 (ets domain transcription factor) | Transcription factors
| | | | | Expressed in all |
ELF2 | E74-like factor 2 (ets domain transcription factor) | Transcription factors
| | | | | Expressed in all |
ELF3 | E74-like factor 3 (ets domain transcription factor, epithelial-specific ) | Cancer-related genes Transcription factors
| | | | | Mixed |
ELF4 | E74-like factor 4 (ets domain transcription factor) | Cancer-related genes Disease related genes Transcription factors
| | | | | Mixed |
ELK1 | ELK1, member of ETS oncogene family | RAS pathway related proteins Transcription factors
| | | | | Expressed in all |
ELK3 | ELK3, ETS-domain protein (SRF accessory protein 2) | Cancer-related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
ELK4 | ELK4, ETS-domain protein (SRF accessory protein 1) | Cancer-related genes Transcription factors
| | | | | Expressed in all |
ELMSAN1 | ELM2 and Myb/SANT-like domain containing 1 | Transcription factors
| | | | | Expressed in all |
EN1 | Engrailed homeobox 1 | Transcription factors
| | | | | Tissue enhanced |
ESR1 | Estrogen receptor 1 | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
ESRRA | Estrogen-related receptor alpha | Nuclear receptors Transcription factors
| | | | | Expressed in all |
ESX1 | ESX homeobox 1 | Transcription factors
| | | | | Tissue enriched |
ETS1 | V-ets avian erythroblastosis virus E26 oncogene homolog 1 | Plasma proteins RAS pathway related proteins Transcription factors
| | | | | Expressed in all |
ETV3 | Ets variant 3 | Plasma proteins Transcription factors
| | | | | Expressed in all |
ETV4 | Ets variant 4 | Cancer-related genes Transcription factors
| | | | | Mixed |
ETV5 | Ets variant 5 | Cancer-related genes Transcription factors
| | | | | Mixed |
ETV6 | Ets variant 6 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
ETV7 | Ets variant 7 | Transcription factors
| | | | | Mixed |
FOS | FBJ murine osteosarcoma viral oncogene homolog | Cancer-related genes Transcription factors
| | | | | Expressed in all |
FOSL1 | FOS-like antigen 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
FOSL2 | FOS-like antigen 2 | Transcription factors
| | | | | Expressed in all |
FOXA1 | Forkhead box A1 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
FOXA2 | Forkhead box A2 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
FOXC1 | Forkhead box C1 | Disease related genes Plasma proteins Transcription factors
| | | | | Tissue enriched |
FOXJ1 | Forkhead box J1 | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enriched |
FOXJ2 | Forkhead box J2 | Transcription factors
| | | | | Expressed in all |
FOXK1 | Forkhead box K1 | Transcription factors
| | | | | Mixed |
FOXK2 | Forkhead box K2 | Transcription factors
| | | | | Expressed in all |
FOXM1 | Forkhead box M1 | Cancer-related genes Transcription factors
| | | | | Mixed |
FOXN2 | Forkhead box N2 | Transcription factors
| | | | | Expressed in all |
FOXO1 | Forkhead box O1 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |